Synthetic cannabinoids: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Category:Tox" to "Category:Toxicology") |
|||
| Line 24: | Line 24: | ||
==See Also== | ==See Also== | ||
*[[Sympathomimetic toxicity]] | *[[Sympathomimetic toxicity]] | ||
*[[Marijuana]] | |||
==Source== | ==Source== | ||
Revision as of 23:06, 12 May 2016
Background
- Common names: spice, K2, Moon Rocks, Blue Lotus, many others
- Active ingredients: cannabicyclohexano, JWH-018, JWH-073, HU-210, XLR-11, others
- Far more potent than THC (100-800x)
- Cannabinoid receptor agonists (CB1 or CB2)
- Do not show up as marijuana on routine tox testing
- Generally smoked, but can be drank as a tea
Clinical Features
- Similar effect to marijuana at low doses, but may be more intense and cause an acute agitated delerium
- Typical effects 10-30 min and taper over 1-2 hours
- Tachycardia and hypertension common (distinguishing it from MJ use)
- Adverse effects: nausea, vomiting, diaphoresis, anxiety, paranoia, hallucinations, agitation, deli
- Use has been associated with AKI and acute cerebral ischemia.[1][2]
Differential Diagnosis
Sympathomimetics
- Cocaine
- Amphetamines
- Synthetic cathinones (khat)
- Ketamine
- Ecstasy (MDMA)
- Synthetic cannabinoids
- Bath salts
Treatment
- Supportive
- Benzodiazepines
- Zofran
See Also
Source
David Burbulys, MD lecture 9/2012
- ↑ Buser GL, Gerona RR, Horowitz BZ, et al. Acute kidney injury associated with smoking synthetic cannabinoid. Clin Toxicol (Phila). 2014;52(7):664–73.
- ↑ Takematsu M, Hoffman RS, Nelson LS, Schechter JM, Moran JH, Wiener SW. A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid. Clin Toxicol (Phila). 2014;52(9):973–5.